Cita APA

Wang, D., Zeng, C., Xu, B., Xu, J., Wang, J., Jiang, L., . . . Zhou, J. (2020). Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients. Blood Cancer J.

Citación estilo Chicago

Wang, D., et al. "Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for Relapsed/refractory CD30(+) Lymphoma Patients." Blood Cancer J 2020.

Cita MLA

Wang, D., et al. "Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for Relapsed/refractory CD30(+) Lymphoma Patients." Blood Cancer J 2020.